Trial Profile
Clinical Trials Insight: 700012826
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 30 Mar 2006
Price :
$35
*
At a glance
- Drugs Fosbretabulin (Primary)
- Indications Head and neck cancer; Non-small cell lung cancer; Prostate cancer
- Focus Adverse reactions
- Sponsors Mateon Therapeutics
- 30 Mar 2006 New trial record.